Home | NRI | Business Associates | Knowledge Bank | Careers | Back Office | Contact Us
 
Board Meetings
 
Today's Board Meetings Forthcoming Board Meetings
Board Meetings
Company NameDatePurpose
Aarti Pharma 09-Feb-26 Aarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 inter alia to consider and approve 1. Unaudited Financial Results of the Company for the quarter and nine-months ended December 31 2025 after these results are reviewed by the Audit Committee of the Board. 2. Declaration of Interim Dividend if any on the equity share capital of the Company for the Financial Year 2025-26. AARTI PHARMALABS LIMITED has informed the Exchange about Board Meeting to be held on 09-Feb-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 31, 2025 and Dividend/Other business.
Abans Financial 09-Feb-26 Abans Financial Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 inter alia to consider and approve Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter and nine months ended on December 31 2025.
AGI Infra 09-Feb-26 AGI Infra Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 inter alia to consider and approve Pursuant to provisions of Regulations 29 & 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Monday February 09 2026 at the registered office of the Company inter-alia to consider and approve Unaudited Consolidated and Standalone Financial Results of the Company for the quarter ended 31.12.2025 and along with limited review of Auditors thereon.
Alan Scott Ente. 09-Feb-26 Alan Scott Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 inter alia to consider and approve (1) Approval of unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended December 31 2025; (2) Other matters as per the agenda of the Board meeting
All Time Plastic 09-Feb-26 Quarterly Results
 < Back Top
BSE Disclaimer     |     Disclaimer     |     Privacy Statement     |     Terms of Use     |     Feedback     |    Sitemap     |    Downloads    |     Client Bank Details
Useful Links   | Risk Disclosure   | Rules and Regulations   |   Investor Charter / Complaints   |   Smart ODR   |   Scores   |   Attention Investors   | Audit Compliance Report   | RA – Annual Compliance Audit Report 2024-25   | UPI IDs for Payment

SEBI Saa₹thi Mobile App/SEBI Investor Website  

SSJ FINANCE & SECURITIES PRIVATE LIMITED:
1st Floor, Merchant Chamber, Opp. Patkar Hall, 41, New Marine Lines, Mumbai – 400 020
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822
SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481|Research Analyst SEBI Reg. No.INH000001527
2006-07 © SSJ Finance & Securities Pvt. Ltd. All Rights Reserved Developed & Maintained By C-MOTS Infotech(ISO 9001:2015 certified)
Content powered by Capital Market Charts are powered by TradingView